
CNRS Île-de-France / Gif-sur-Yvette regularly showcases research-driven startups emerging from its laboratories and scientific ecosystem. Its editorial focus emphasizes projects that successfully translate fundamental research into concrete technological and medical applications.
In 2023, CNRS featured Beams in an article dedicated to its work on improving exhaustive tumor ablation during surgical procedures. The publication highlights the development of an innovative detection tool designed to assist surgeons in identifying residual tumor tissues in real time, addressing a critical challenge in oncological surgery.
The article places particular emphasis on the scientific origins of the technology, rooted in nuclear physics and medical research conducted within the CNRS and academic environment. It illustrates how long-term research efforts, combined with close collaboration between scientists, engineers, and clinicians, can lead to meaningful advances in patient care.
This institutional recognition reinforces Beams’ position as a research-based medtech startup and highlights the importance of strong public research ecosystems in enabling innovation at the interface of science and medicine.
Explore the latest advances, clinical insights, and technology shaping the future of intraoperative tumor detection. Stay informed with expert perspectives from Beams and our partners.
Back to news
Beams’ co-founder and president, Virginie Simon, was recently profiled by Les Deeptech, an initiative of Bpifrance highlighting deeptech leaders. The feature shares Virginie’s inspiring journey and the vision driving Beams as it develops innovative tools to transform intraoperative cancer care.
Read article
As part of the 10th anniversary of the 3DEXPERIENCE Lab acceleration program, Beams was invited to present its technology on BFM Business. This opportunity allowed us to share our mission, our scientific roots, and our approach to improving surgical precision through real-time intraoperative tumor detection.
Read article
In 2023, Beams was selected as a laureate of the i-Lab Innovation Competition, France’s leading national program supporting deeptech startups. This milestone recognizes the scientific maturity of the project and supports the transition from advanced research to pre-industrial medical technologies.
Read article
In 2023, Beams was selected in the Challenges magazine list of the 100 startups to invest in, a benchmark ranking highlighting the most promising French technology ventures. This recognition underscores the relevance of Beams’ scientific approach and its long-term potential in medical and nuclear technologies.
Read article
In 2023, Challenges magazine published a dedicated article highlighting Beams’ work in developing intelligent technologies to improve cancer treatment. This media coverage reflects the growing recognition of Beams’ approach at the intersection of science, healthcare, and deeptech innovation.
Read article
In 2023, Université Paris-Saclay published an article highlighting Beams’ work in medical technologies serving surgical oncology. This recognition emphasizes the strong scientific foundations of the project and its roots in academic research translated into clinical innovation.
Read article
In 2023, Techniques de l’Ingénieur published an article highlighting Beams’ work on real-time detection of tumor tissues during surgery. This coverage emphasizes the technological and scientific foundations of the solution, as well as its potential impact on surgical oncology.
Read article